Related Experiment Video
Updated: Jun 25, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Comorbidity-Guided Text Mining and Omics Pipeline to Identify Candidate Genes and Drugs for Alzheimer's Disease
Iyappan Ramalakshmi Oviya1, Divya Sankar2, Sharanya Manoharan3
1Department of Computer Science and Engineering, Amrita School of Computing, Amrita Vishwa Vidyapeetham, Chennai 641112, India.
Abstract:
Alzheimer's disease (AD), a multifactorial neurodegenerative disorder, is prevalent among the elderly population. It is a complex trait with mutations in multiple genes. Although the US Food and Drug Administration (FDA) has approved a few drugs for AD treatment, a definitive cure remains elusive. Research efforts persist in seeking improved treatment options for AD. Here, a hybrid pipeline is proposed to apply text mining to identify comorbid diseases for AD and an omics approach to identify the common genes between AD and five comorbid diseases-dementia, type 2 diabetes, hypertension, Parkinson's disease, and Down syndrome. We further identified the pathways and drugs for common genes. The rationale behind this approach is rooted in the fact that elderly individuals often receive multiple medications for various comorbid diseases, and an insight into the genes that are common to comorbid diseases may enhance treatment strategies. We identified seven common genes-PSEN1, PSEN2, MAPT, APP, APOE, NOTCH, and HFE-for AD and five comorbid diseases. We investigated the drugs interacting with these common genes using LINCS gene-drug perturbation. Our analysis unveiled several promising candidates, including MG-132 and Masitinib, which exhibit potential efficacy for both AD and its comorbid diseases. The pipeline can be extended to other diseases.
Insights
This study identifies common genes between Alzheimer's disease (AD) and comorbid conditions like dementia and diabetes. It suggests potential drugs like MG-132 for treating AD and related diseases.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Alzheimer's disease (AD) is a prevalent neurodegenerative disorder in the elderly, characterized by complex genetic factors.
- Current AD treatments are limited, highlighting the need for novel therapeutic strategies.
- Elderly patients often have multiple comorbid conditions, complicating treatment plans.
Purpose of the Study:
- To identify diseases comorbid with Alzheimer's disease using text mining.
- To pinpoint common genes shared between AD and five major comorbid diseases: dementia, type 2 diabetes, hypertension, Parkinson's disease, and Down syndrome.
- To discover potential therapeutic drugs targeting these common genes for enhanced treatment strategies.
Main Methods:
- A hybrid pipeline combining text mining and omics approaches was developed.
- Text mining identified comorbid diseases associated with AD.
- Omics analysis pinpointed common genes and pathways between AD and its comorbidities, followed by gene-drug interaction analysis using LINCS perturbation.
Main Results:
- Seven common genes (PSEN1, PSEN2, MAPT, APP, APOE, NOTCH, HFE) were identified between AD and the five comorbid diseases.
- Analysis revealed potential drug candidates, including MG-132 and Masitinib, targeting these common genes.
- These identified drugs show promise for treating both AD and its comorbid conditions.
Conclusions:
- The study successfully identified shared genetic factors and potential therapeutic targets for AD and its common comorbidities.
- The proposed hybrid pipeline offers a novel approach for drug discovery in complex, multifactorial diseases.
- The findings suggest that targeting common genes could lead to more effective, integrated treatment strategies for elderly patients with multiple conditions.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Alzheimer's Disease: Treatment
Genomics

